The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury - ScienceDirect
![sitagliptin [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b "sitagliptin [TUSOM | Pharmwiki]")
sitagliptin [TUSOM | Pharmwiki]
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text
IJMS | Free Full-Text | Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Anti-obesity drugs are closing the gap between dieting and bariatric surgery | Diet and Nutrition | Prevention | UT Southwestern Medical Center
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy
Frontiers | GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Frontiers | Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor | Journal of Medicinal Chemistry
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes | Nature Reviews Nephrology
![Mechanism of action of GLP-1 [25]. | Download Scientific Diagram](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png "Mechanism of action of GLP-1 [25]. | Download Scientific Diagram")
Mechanism of action of GLP-1 [25]. | Download Scientific Diagram
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 - ScienceDirect
Mechanism Of Action Of GLP-1 Agonists - My Endo Consult
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Pharmacy Pearl
![glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "glp-1_analogs [TUSOM | Pharmwiki]")
glp-1_analogs [TUSOM | Pharmwiki]
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports
Glucagon-like Peptide (GLP-1) and the treatment of diabetes - YouTube
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes | Circulation
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist - YouTube
Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
Mechanisms by which GLP-1 agonists may exert beneficial effects on the... | Download Scientific Diagram
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia - Daria Ja'arah, Mazhar Salim Al Zoubi, Gamal Abdelhady, Firas Rabi, Murtaza M Tambuwala, 2021
